Who owns FREELINE THERAPEUTICS HOLDINGS?
- CUSIP Number: 35655l206
Tip: Access positions for across all investors
Analyze quarterly positions in Freeline Therapeutics Holdings with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Freeline Therapeutics Holdings stock
Who bought or sold FREELINE THERAPEUTICS HOLDINGS this quarter?
There are no current stakeholders of Freeline Therapeutics Holdings.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Freeline Therapeutics Holdings?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2023 | 99k | $633k |
| Blue Owl Capital Holdings | Dec 2023 | 87k | $552k |
| Jpmorgan Chase & Co | Dec 2023 | 67k | $427k |
| PenderFund Capital Management | Dec 2023 | 60k | $509k |
| Morgan Stanley | Sep 2023 | 42k | $183k |
| Harbor Capital Advisors | Dec 2023 | 20k | $129k |
| Sphera Funds Management | Dec 2023 | 16k | $105k |